Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated:  8/24/2015
Emory University School of Medicine
mi
from
Atlanta, GA
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated: 8/24/2015
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated:  8/24/2015
Loyola University Medical Center
mi
from
Maywood, IL
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated: 8/24/2015
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated:  8/24/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated: 8/24/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated:  8/24/2015
Cleveland Clinic
mi
from
Cleveland, OH
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated: 8/24/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated:  8/24/2015
Minor and James
mi
from
Seattle, WA
Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
A TRIAL OF LETROZOLE IN PULMONARY LYMPHANGIOLEIOMYOMATOSIS
Status: Enrolling
Updated: 8/24/2015
Minor and James
mi
from
Seattle, WA
Click here to add this to my saved trials
Bariatric Surgery and the Kidney
Study of Renal Parameters After Bariatric Surgical Weight Loss
Status: Enrolling
Updated:  8/26/2015
University Hospital
mi
from
Indianapolis, IN
Bariatric Surgery and the Kidney
Study of Renal Parameters After Bariatric Surgical Weight Loss
Status: Enrolling
Updated: 8/26/2015
University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated:  8/28/2015
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated: 8/28/2015
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated:  8/28/2015
Children's Healthcare of Atlanta at Egleston - Pediatric Intensive Care Unit
mi
from
Atlanta, GA
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated: 8/28/2015
Children's Healthcare of Atlanta at Egleston - Pediatric Intensive Care Unit
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated:  8/28/2015
Medical Center of Central Georgia - Pediatric Intensive Care Unit
mi
from
Macon, GA
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated: 8/28/2015
Medical Center of Central Georgia - Pediatric Intensive Care Unit
mi
from
Macon, GA
Click here to add this to my saved trials
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated:  8/31/2015
Stanford University
mi
from
Stanford, CA
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated: 8/31/2015
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated:  8/31/2015
Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated: 8/31/2015
Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Click here to add this to my saved trials
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated:  8/31/2015
St. Joseph's Health Care
mi
from
London,
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated: 8/31/2015
St. Joseph's Health Care
mi
from
London,
Click here to add this to my saved trials
Computer Decision Support to Achieve Glycemic Control in the ICU
Computer Decision Support to Achieve Glycemic Control in the ICU
Status: Enrolling
Updated:  9/1/2015
U.S. Army Institute of Surgical Research
mi
from
Fort Sam Houston, TX
Computer Decision Support to Achieve Glycemic Control in the ICU
Computer Decision Support to Achieve Glycemic Control in the ICU
Status: Enrolling
Updated: 9/1/2015
U.S. Army Institute of Surgical Research
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Soy Nut Study on Markers of Health
Effects of Soy on Metabolite Markers of Health
Status: Enrolling
Updated:  9/2/2015
Ragle Human Nutrition Center
mi
from
Davis, CA
Soy Nut Study on Markers of Health
Effects of Soy on Metabolite Markers of Health
Status: Enrolling
Updated: 9/2/2015
Ragle Human Nutrition Center
mi
from
Davis, CA
Click here to add this to my saved trials
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated:  9/2/2015
California Pacific Medical Center (CPMC)
mi
from
San Francisco, CA
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated: 9/2/2015
California Pacific Medical Center (CPMC)
mi
from
San Francisco, CA
Click here to add this to my saved trials
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated:  9/2/2015
Unversity of Colorado Denver
mi
from
Aurora, CO
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated: 9/2/2015
Unversity of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated:  9/2/2015
Borland-Groover Clinic
mi
from
Jacksonville, FL
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated: 9/2/2015
Borland-Groover Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated:  9/2/2015
The University of Chicago Medical Center (UCMC)
mi
from
Chicago, IL
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated: 9/2/2015
The University of Chicago Medical Center (UCMC)
mi
from
Chicago, IL
Click here to add this to my saved trials
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated:  9/2/2015
Cornell University
mi
from
New York, NY
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated: 9/2/2015
Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated:  9/2/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated: 9/2/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated:  9/2/2015
Hospital Costa del Sol
mi
from
Marbella,
AXIOS Stent & Delivery System Study
A Prospective, Multi-center, Non-blinded, Single-arm (Nonrandomized) Study of the AXIOS Stent and Delivery System
Status: Enrolling
Updated: 9/2/2015
Hospital Costa del Sol
mi
from
Marbella,
Click here to add this to my saved trials
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated:  9/2/2015
University of Colorado Denver
mi
from
Aurora, CO
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated: 9/2/2015
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated:  9/2/2015
Baptist Medical Center
mi
from
Jacksonville, FL
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated: 9/2/2015
Baptist Medical Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated:  9/2/2015
Florida Hospital
mi
from
Orlando, FL
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated: 9/2/2015
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated:  9/2/2015
Emory University
mi
from
Atlanta, GA
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated: 9/2/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated:  9/2/2015
University of Chicago Medical Center
mi
from
Chicago, IL
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated: 9/2/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated:  9/2/2015
Johns Hopkins University
mi
from
Baltimore, MD
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated: 9/2/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated:  9/2/2015
Washington University, St. Louis
mi
from
St. Louis, MO
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated: 9/2/2015
Washington University, St. Louis
mi
from
St. Louis, MO
Click here to add this to my saved trials
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated:  9/2/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
AXIOS Stent With Electrocautery Enhanced Delivery System
AXIOS Stent With Electrocautery Enhanced Delivery System
Status: Enrolling
Updated: 9/2/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Azusa, CA
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Azusa, CA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Costa Mesa, CA
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Lynwood, CA
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Lynwood, CA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Riverside, CA
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
San Diego, CA
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Denver, CO
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Macon, GA
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Macon, GA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Shreveport, LA
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Brooklyn Center, MN
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Brooklyn Center, MN
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Houston, TX
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Chesapeake, VA
Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
A Double-Blind, Randomized, Placebo-Controlled Multiple Ascending Dose Study to Assess the Safety, Tolerability and Efficacy of KAI-4169 in Hemodialysis Subjects With Secondary Hyperparathyroidism
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Promoting Adherence to Sleep Apnea Treatment Among Blacks With Metabolic Syndrome
Promoting Adherence to Sleep Apnea Treatment Through Health Education Among Blacks With Metabolic Syndrome
Status: Enrolling
Updated:  9/9/2015
New York University
mi
from
New York, NY
Promoting Adherence to Sleep Apnea Treatment Among Blacks With Metabolic Syndrome
Promoting Adherence to Sleep Apnea Treatment Through Health Education Among Blacks With Metabolic Syndrome
Status: Enrolling
Updated: 9/9/2015
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia
A Novel Therapeutic Modality for Congenital Adrenal Hyperplasia
Status: Enrolling
Updated:  9/10/2015
BCM, Texas Children's Hospital Clinic and General Clinical Research Center
mi
from
Houston, TX
Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia
A Novel Therapeutic Modality for Congenital Adrenal Hyperplasia
Status: Enrolling
Updated: 9/10/2015
BCM, Texas Children's Hospital Clinic and General Clinical Research Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females With Polycystic Ovary Syndrome
Status: Enrolling
Updated:  9/14/2015
Miami Research Associates
mi
from
Miami, FL
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females With Polycystic Ovary Syndrome
Status: Enrolling
Updated: 9/14/2015
Miami Research Associates
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females With Polycystic Ovary Syndrome
Status: Enrolling
Updated:  9/14/2015
Clinical Research Facility
mi
from
Orlando, FL
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females With Polycystic Ovary Syndrome
Status: Enrolling
Updated: 9/14/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females With Polycystic Ovary Syndrome
Status: Enrolling
Updated:  9/14/2015
Clinical Research Facility
mi
from
Springfield, MO
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females With Polycystic Ovary Syndrome
Status: Enrolling
Updated: 9/14/2015
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females With Polycystic Ovary Syndrome
Status: Enrolling
Updated:  9/14/2015
mi
from
Berlin,
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females With Polycystic Ovary Syndrome
Status: Enrolling
Updated: 9/14/2015
mi
from
Berlin,
Click here to add this to my saved trials
Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism
Concomitant Use of Growth Hormone and GnRH Agonist in Adolescent Patients With Acquired Hypothyroidism
Status: Enrolling
Updated:  9/18/2015
Baylor College of Medicine
mi
from
Houston, TX
Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism
Concomitant Use of Growth Hormone and GnRH Agonist in Adolescent Patients With Acquired Hypothyroidism
Status: Enrolling
Updated: 9/18/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
An Exploratory Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Design Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD1722 in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
Status: Enrolling
Updated:  9/18/2015
Creekside Endocrine Associates PC
mi
from
Denver, CO
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
An Exploratory Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Design Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD1722 in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
Status: Enrolling
Updated: 9/18/2015
Creekside Endocrine Associates PC
mi
from
Denver, CO
Click here to add this to my saved trials
Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants
Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants
Status: Enrolling
Updated:  9/21/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants
Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants
Status: Enrolling
Updated: 9/21/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials